Debated: Nonfactor Versus Gene Therapy for Hemophilia

Whether hemophilia A patients should stick with effective nonfactor therapy or join a clinical trial for a potential cure with gene therapy – this question was debated at he annual meeting of the European Hematology Association. Ultimately, results of a very informal polling of the online audience suggested a strong leaning toward the known benefits of nonfactor therapy, as opposed […]
Continue reading »